SoftOx Solutions AS (SOFTX) fair value: what the stock is really worth
We calculate from audited financials what SoftOx Solutions AS is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Valuation from Jun 24, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
Watch SoftOx Solutions AS for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 24, 2026.
How to read this chart
60‑month range kr 0.0110 – kr 77.00 · fair‑value band kr 0.0255 – kr 0.0425 · the kr 0.1184 price screens above the kr 0.0340 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jun 24, 2026.
Follow SoftOx Solutions AS in your weekly email
Every Wednesday you see whether SoftOx Solutions AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections.
Show more
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.
Stock analysis
SoftOx Solutions AS (SOFTX) currently trades at kr 0.1184, while our model-based Fair Value estimate is kr 0.0340, implying the stock looks roughly 248.2% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 95/100, which puts the evidence level at low.
Scenario range: kr 0.0255 (bear) to kr 0.0425 (bull), the price of kr 0.1184 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
SoftOx Solutions AS reported revenue of 15.6M NOK in FY2025 versus 7.9M NOK in FY2021, a compound +18.5%/yr. Reported net income was −10.8M NOK in FY2025.
Key figures
Market cap 283M NOK (≈ $29.7M) · P/S ratio 15.0 · Net margin −69.4% · Return on equity −27.8% · Return on assets (EBIT) −58.2% · Operating margin −131% · Revenue (TTM) 16.3M NOK · Revenue growth (YoY) +21.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 25% below its 52-week high and 116% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −5% fair-value upside, at −71%, SOFTX screens richer than that median.
Fair Value models
Bear kr 0.0255Fair Value kr 0.0340Bull kr 0.0425
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.26/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+96.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+29.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.6%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+75.0%
’16
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−522.0% (2020) → −73.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 649 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score53 · Above median
Fair Value upside−71% · Bottom 25%
Profitability
Return on assets−14% · Below median
Net margin (TTM)−110% · Bottom 25%
Operating margin (TTM)−131% · Bottom 25%
Growth and dividend
Revenue growth21% · Above median
Valuation Multiplesvs Biotechnology median · lower = cheaper
P/B1.29× · Cheaper than median
P/S (TTM)1.82× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 0
PAST (return on equity)0· sector 0
HEALTH (low debt)100· sector 97
DIVIDEND (yield)0· sector 23
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "SoftOx Solutions AS Fair Value". https://www.fairvalue-calculator.com/stock/SOFTX
Frequently asked questions
Is SoftOx Solutions AS (SOFTX) overvalued or undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 0.0340 versus a price of kr 0.1184, about −71% upside (overvalued).
What is the fair value of SOFTX?
Our model-based fair value for SoftOx Solutions AS is kr 0.0340 (as of Jun 24, 2026), built from audited fundamentals. The current price: kr 0.1184.
What is the quality score of SOFTX?
SoftOx Solutions AS has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for SoftOx Solutions AS (SOFTX)?
Our model-based price target is the fair value of kr 0.0340 (as of Jun 24, 2026) from 1 valuation models. Cautious scenario kr 0.0255, optimistic scenario kr 0.0425. It is a calculation from audited fundamentals, not an analyst target.
What is the SoftOx Solutions AS stock forecast for 2026?
Our models put fair value at kr 0.0340, about −71% upside versus a price of kr 0.1184 (overvalued). Cautious scenario kr 0.0255, optimistic scenario kr 0.0425. The calculation is refreshed regularly with new filings.
What is the revenue of SoftOx Solutions AS (SOFTX)?
SoftOx Solutions AS reported trailing-twelve-month revenue of about 16.3M NOK (latest available figure, as of Jun 24, 2026).
What is the intrinsic value of SoftOx Solutions AS (SOFTX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For SoftOx Solutions AS it is kr 0.0340 per share (as of Jun 24, 2026), against a price of kr 0.1184. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is SoftOx Solutions AS stock overvalued or undervalued in 2026?
As of Jun 24, 2026, SOFTX trades above its calculated fair value: price kr 0.1184, fair value kr 0.0340, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of SOFTX?
No. The price is what the market pays today (kr 0.1184); the fair value is what the company's own numbers justify (kr 0.0340). For SoftOx Solutions AS the two are kr 0.0844 per share apart. That gap is exactly why we show both numbers side by side.
How much is SoftOx Solutions AS worth?
The market values SoftOx Solutions AS at about 283M NOK (market capitalisation, as of Jun 24, 2026). Per share that is kr 0.1184; our models calculate a fair value of kr 0.0340 per share.
What do the bullish and bearish scenarios say about SOFTX?
Our models span a range for SoftOx Solutions AS: cautious scenario kr 0.0255, base kr 0.0340, optimistic kr 0.0425 per share (as of Jun 24, 2026, price kr 0.1184). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of SoftOx Solutions AS (SOFTX)?
Balance-sheet figures for SoftOx Solutions AS (as of Jun 24, 2026): return on equity −27.8%. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
How far is SOFTX from its 52-week high?
SoftOx Solutions AS trades at kr 0.1184, about 25% below its 52-week high of kr 0.1570 and 116% above the low of kr 0.0548 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.0340 is for.
Which stocks are comparable to SoftOx Solutions AS?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, argenx SE, Samsung Biologics Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is SoftOx Solutions AS stock attractive at the current price?
The data as of Jun 24, 2026: price kr 0.1184, calculated fair value kr 0.0340 (−71%), Quality Score 50/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of SOFTX calculated?
We run SoftOx Solutions AS through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.0340, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. SoftOx Solutions AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of SoftOx Solutions AS (SOFTX)?
The closing price on Sep 24, 2026 was kr 0.1184. Our model-based fair value is kr 0.0340, about −71% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with SoftOx Solutions AS right now?
The price sits above even our optimistic bull case (kr 0.0425). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of SoftOx Solutions AS
How large is the market capitalisation of SoftOx Solutions AS (SOFTX)?
The market capitalisation of SoftOx Solutions AS is 283M NOK (≈ $29.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of SoftOx Solutions AS (SOFTX)?
The price-to-sales ratio of SoftOx Solutions AS is 15.0 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of SoftOx Solutions AS (SOFTX)?
The net margin of SoftOx Solutions AS is −69.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of SoftOx Solutions AS (SOFTX)?
The return on equity (ROE) of SoftOx Solutions AS is −27.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of SoftOx Solutions AS (SOFTX)?
On an EBIT basis the return on assets of SoftOx Solutions AS is −58.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of SoftOx Solutions AS (SOFTX)?
The operating margin of SoftOx Solutions AS is −131% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at SoftOx Solutions AS (SOFTX)?
Revenue at SoftOx Solutions AS is growing +21.3% versus a year earlier (3y avg +29.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does SoftOx Solutions AS (SOFTX) generate?
The free cash flow of SoftOx Solutions AS is −18.9M NOK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does SoftOx Solutions AS (SOFTX) carry?
The net debt of SoftOx Solutions AS is 66.3M NOK (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch SoftOx Solutions AS in the live analysis
One click puts SoftOx Solutions AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
